Action Will Provide New Therapy for Growing Public Health Issue

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) replication, normalise liver enzymes, and slow disease progression with excellent ...

Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity...

Nature Reviews Gastroenterology & Hepatology, Published online: 19 June 2025; doi:10.1038/s41575-025-01093-5Liver xenotransplantation and genetically engineered pig livers have potential to save human lives. Liver xenotransplants can either act as a bridge to allotransplantation or support the recovery and regeneration of a whole or reduced native liver in acute liver failure and in major hepatectomies through ex vivo perfusion or auxiliary liver xenotransplantation.

This link will take you to a page that’s not on LinkedIn

Chronic hepatitis B is the leading cause of hepatocellular carcinoma and a significant global health issue, affecting over 296 million people worldwide, with 15 million people coinfected with hepatiti...

25 – 26 mars 2025 à Lyon Séminaire ACHBPT à l’Hôpital de la Croix-Rousse à Lyon – Salle Vaïsse Organisation : ACHBPT Institut d’Hépatologie de Lyon, IHU EVEREST Association à but scientifique pour l’a...

Monday, February 3rd 2025 IHU Everest is organizing a Symposium on liver organoids and 3D ex-vivo models.This event will be held on Monday, February 3rd 2025, at CarMeN laboratory, on the Lyon-Sud hos...

Nature Reviews Gastroenterology & Hepatology, Published online: 13 January 2025; doi:10.1038/s41575-025-01036-0Drug approvals in gastroenterology and hepatology in 2024

Why does hepatitis B, which can lead to liver cancer, often go undetected, even though tests exist?

YouTube video by Hepatitis B Foundation

YouTube video by Gastroenterology at BMJ